Skip to main content

Human CD99 Biotinylated Antibody

R&D Systems, part of Bio-Techne | Catalog # BAF3968

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
BAF3968

Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human

Applications

Validated:

Western Blot

Cited:

Western Blot

Label

Biotin

Antibody Source

Polyclonal Goat IgG

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant human CD99
Asp23-Asp122
Accession # P14209

Specificity

Detects human CD99 in Western blots. In Western blots, less than 5% cross‑reactivity with recombinant mouse CD99 is observed.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Applications for Human CD99 Biotinylated Antibody

Application
Recommended Usage

Western Blot

0.1 µg/mL
Sample: Recombinant Human CD99 Fc Chimera (Catalog # 3968-CD)
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CD99

CD99 (also named MIC2, E2 and thymic leukemia antigen) is the founding member of the CD99 family of molecules. The CD99 family contains four members; CD99, CD99L2, XG and the pseudogene CD99L1 (1, 2, 3). Native human CD99 is 32 kDa in size and exists as a type I transmembrane glycoprotein. This is referred to as the long, or type I isoform. It is synthesized as a 185 amino acid (aa) precursor that contains a 22 aa signal sequence, a 100 aa extracellular domain (ECD), a 25 aa transmembrane segment, and a 38 aa cytoplasmic region (4). The ECD contains no identifiable motifs, N‑linked glycosylation sites, or cysteine residues; it does possess sites for O-linked glycosylation. The cytoplasmic region, albeit short, does have signal transduction capability (5). There are apparently multiple isoforms for human CD99. One shows a 16 aa deletion in the ECD (aa 34‑49), a second shows a 38 aa deletion in the cytoplasmic region (aa 122‑159), and a third exhibits a three aa truncation at the C-terminus (6, 7, 8). The best studied isoform shows an Asp‑Gly substitution for the C‑terminal 27 amino acids. This is referred to as the 28 kDa type II isoform (9). The type I and II isoforms have distinctive signal transduction pathways (FAK-src for type I; PI3K plus src-ERK1/2 for type II), and mediate clearly different biological outcomes (5, 9, 10). The two numbered isoforms may or may not co‑exist on the same cells. Peripheral T cells have only the long isoform, while double-positive thymocytes express both isotypes. What is unclear is the monomeric vs. dimeric status of CD99. In mouse, CD99 reportedly forms disulfide-linked homodimers (11). In human, however, CD99 is reportedly monomeric if only a type I isoform, and a covalent heterodimer if co‑expressing type I and II isoforms (12, 13). Cells known to express CD99 include fibroblasts, neutrophils, T cells, double-positive thymocytes, CD34+ stem cells, monocytes and endothelial cells (2, 12, 14, 15). Homophilic interaction between CD99 on the neutrophil and CD99 on the endothelial cell regulates the transendothelial migration of neutrophils during inflammation (16). Human CD99 is only 48% aa identical to mouse CD99 (17).

References

  1. Wilson, M.D. et al. (2006) Physiol Genomics 27:201. 
  2. Petri, B. and M.G. Bixel (2006) FEBS J. 273:4399. 
  3. Suh, Y.H. et al. (2003) Gene 307:63. 
  4. Gelin, C. et al. (1989) EMBO J. 8:3253. 
  5. Byun, H-J. et al. (2006) J. Biol. Chem. 281:34833. 
  6. GenBank Accession # EAW98698. 
  7. GenBank Accession # EAW98699. 
  8. GenBank Accession # EAW98700. 
  9. Hahn, H-J. et al. (1997) J. Immunol. 159:2250.
  10. Scotlandi, K. et al. (2007) Oncogene Apr 30; [Epub ahead of print].
  11. Park, S.H. et al. (2005) Gene 353:177.
  12. Schenkel, A.R. et al. (2002) Nat. Immunol. 3:143.
  13. Alberti, I. et al. (2002) FASEB J. 16:1946.
  14. Imbert, A-M. et al. (2006) Blood 108:2578.
  15. Dworzak, M.N. et al. (1994) Blood 83:415.
  16. Lou, O. et al. (2007) J. Immunol. 178:1136
  17. Shiratori, I. et al. (2004) J. Exp. Med. 199:525.

Alternate Names

CD99, MIC2, pilr-1, PILR-L

Entrez Gene IDs

4267 (Human); 673094 (Mouse); 652929 (Rat)

Gene Symbol

CD99

UniProt

Additional CD99 Products

Product Documents for Human CD99 Biotinylated Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human CD99 Biotinylated Antibody

For research use only

Loading...
Loading...
Loading...
Loading...